Clinical Trials Logo

Filter by:
NCT ID: NCT00235768 Completed - Psychopathology Clinical Trials

The NeXT Study; The Netherlands XTC Toxicity Study

Start date: April 2002
Phase: Phase 1
Study type: Observational

The purpose of this study is to investigate the possible neurotoxic effects of the party-drug Ecstasy (MDMA)on brain and brain function in humans. Main research questions concern the causality, course and clinical relevance of the neurotoxicity of ecstasy

NCT ID: NCT00235677 Completed - Clinical trials for Gastroesophageal Reflux

Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study

Start date: August 2003
Phase: Phase 3
Study type: Interventional

Aim: To evaluate the therapeutic efficacy of a therapeutic procedure, involving endoscopic suturing, for gastroesophageal reflux disease (GERD) compared to a sham procedure. The hypotheses tested in this study were that active treatment would: 1) decrease the use of antisecretory medication, 2) decrease GERD symptoms, 3) improve quality of life, and 4) reduce esophageal acid exposure.

NCT ID: NCT00235391 Completed - Sickle Cell Disease Clinical Trials

Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload

Start date: October 2005
Phase: Phase 3
Study type: Interventional

This is an open-label, non-randomized, multi-center trial designed to provide expanded access of deferasirox to patients with congenital disorders of red blood cells and chronic iron overload from blood transfusions who cannot adequately be treated with locally approved iron chelators.

NCT ID: NCT00235170 Completed - Clinical trials for Coronary Artery Disease

The Arterial Revascularization Therapies Study Part II.

ARTS II
Start date: February 2003
Phase: Phase 3
Study type: Interventional

The main objective is to compare the effectiveness of coronary stent implantation using the sirolimus-eluting Bx VELOCITY™ balloon expandable stent with that of surgery as observed in ARTS I. Effectiveness is measured in terms of Major Cardiac and Cerebrovascular Events (MACCE) free survival at 1 year.

NCT ID: NCT00235157 Completed - Clinical trials for Renal Artery Stenosis

A Comparison of Coated and Uncoated Stents in Renal Artery Treatment.

GREAT
Start date: November 2001
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to compare the safety and performance of the Palmaz Genesis™ balloon expandable stent, with or without sirolimus coating in the treatment of renal artery stenosis, measured at 6 months follow up via angiography.

NCT ID: NCT00234884 Completed - Clinical trials for Rheumatoid Arthritis

Post-marketing Observational Study in Subjects With Rheumatoid Arthritis

ReAlise
Start date: September 2003
Phase: Phase 4
Study type: Observational

The purpose of this observational study was to observe and assess the long term use, safety, and effectiveness of adalimumab in a normal clinical setting.

NCT ID: NCT00234572 Completed - Acromegaly Clinical Trials

Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly

Start date: May 2000
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to compare the effectiveness of lanreotide autogel to placebo after a single injection. Effectiveness and safety were then also assessed following four fixed-dose injections and after one year of treatment given at titrated doses.

NCT ID: NCT00233818 Completed - Clinical trials for Coronary Artery Disease

FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent

Start date: February 2000
Phase: Phase 1/Phase 2
Study type: Interventional

The objective of this study is to assess the performance and safety of a formulation of the antiproliferative agent, sirolimus coated on modified Bx VELOCITY Balloon-Expandable Stent mounted on the Raptor Over The Wire (OTW) Stent Delivery System (SDS) in patients with de novo coronary artery lesions.

NCT ID: NCT00233662 Completed - Clinical trials for Chronic Plaque Psoriasis

Safety and Tolerability of Repeat Courses of IM Alefacept

Start date: December 1, 2002
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether repeat courses of alefacept, administered intramuscularly, are safe when given to chronic plaque psoriasis patients who are receiving standard dermatology treatments.

NCT ID: NCT00233649 Completed - Clinical trials for Diabetes Mellitus Type 2

DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines

Start date: May 2004
Phase: Phase 4
Study type: Observational

The purpose of this study is to determine in DM II patients the efficacy of Crestor in obtaining the new European LDL cholesterol guidelines.